As of December 2024, Tanvex BioPharma has a market cap of $249.57M. This makes Tanvex BioPharma the world's 15624th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $260.24M | -2.61% |
2023 | $267.22M | 85.47% |
2022 | $144.08M | -39.59% |
2021 | $238.49M | 55.35% |
2020 | $153.52M | -16.42% |
2019 | $183.69M | -27.93% |
2018 | $254.87M | -16.68% |
2017 | $305.91M | -51.13% |
2016 | $625.96M | -32.12% |
2015 | $922.13M | - |